Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study

Bert N. Storm*, Hanieh Abedian Kalkhoran, Erik B. Wilms, Pepijn Brocken, Henk Codrington, Danny Houtsma, Johanneke E. A. Portielje, Nienke de Glas, Daisy van der Ziel, Frederiek van den Bos, Loes E. Visser

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience